Key Insights Given the large stake in the stock by institutions, Vir Biotechnology's stock price might be vulnerable ...

Spatial transcriptomics technologies opened the door for new kinds of biological measurements, allowing scientists to ...

AI systems already work their magic in many areas of biomedical science, helping to solve protein structure, discover hidden ...

BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, ...

Since its origin, Winston-Salem has been a city of big ideas and innovation. The city built international brands – BB&T (now ...

The plant biotechnology market is estimated at USD 51.73 billion in 2025 and is projected to reach USD 76.79 billion by 2030, ...

Engineers at a University of Bristol spin-out company have created a new technology that can move cells without touching them ...

On March 27, the American Association for the Advancement of Science announced University of Nevada, Reno professors Steve ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.